Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Other Research Projects

  1. Rod P Rezaee: Defining the role of PET/CT imaging in the treatment of patients with head and neck cancer. MetroHealth research SPORE grant pending.
  2. James E. Arnold, MD and Robert C. Sprecher, MD: Phase 3 trial to assess efficacy of vaccine for recurrent respiratory papillomatosis (in development).
  3. Steven Houser, MD, Dorr Dearborn, MD, PhD - Department of Pediatric Pulmonology, James E. Arnold, MD: An investigation of the role played by molds in pathogenesis of allergic rhinosinusitis. Sponsored by the Environmental Protection Agency.
  4. Steven Houser, MD: Quality of life evaluation in patients with empty nose syndrome.
  5. Pierre Lavertu, MD, Scot Remick, MD: A Phase I/If Study of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, OSI-774, in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Cancer of the Head and Neck; CWRU 1301.
  6. Pierre Lavertu, MD, Scot Remick, MD: Phase II Trial of Combretastatin A-4 Phosphate (CA4P) in Advanced Anaplastic Carcinoma of the Thyroid; ICC 2302.
  7. Pierre Lavertu, MD: Detection of Pre-cancerous and Cancerous Lesions of the Oropharynx with OpCDx (computer-assisted analysis of brush biopsy specimens): A Multi-center Trial; OSLI 1301
  8. Pierre Lavertu, MD, Scot Remick, MD: Phase TB/If Trial of Combination Modality Combretastatin A-4 Phosphate (CA4P)-based Therapy for Patients with Newly Diagnosed Anaplastic Thyroid Cancer: ICC 3302.
  9. Pierre Lavertu, MD: EndoCDx: Evaluation of Pharyngeal and Laryngeal Lesions with Computer-Assisted Analysis of Brush Biopsy Specimens OSLI 1302.